Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1995 Aug;88(8):441–445.

Intracellular (polymorphonuclear) magnesium content in patients with bronchial asthma between attacks.

P Fantidis 1, J Ruiz Cacho 1, M Marín 1, R Madero Jarabo 1, J Solera 1, E Herrero 1
PMCID: PMC1295297  PMID: 7562826

Abstract

Previous studies have demonstrated the role of polymorphonuclears in asthma, the importance of increases in intracellular concentrations of ionized calcium in the release of chemical mediators, the role of magnesium as natural calcium channel blocker, and the importance of magnesium deficiency in plasma histamine concentration and in tissue prostanoid concentration. The objective of our study was to measure the polymorphonuclear magnesium content in patients with asthma in the interval between attacks. We measured the polymorphonuclear magnesium content, and serum and erythrocyte sodium, calcium, and magnesium concentrations in 21 healthy volunteers and 50 patients with different types of asthma. In our patients, the polymorphonuclear magnesium content was lower than in the control group (P < 0.001), while magnesium levels in erythrocytes and serum and the levels of other ions in erythrocytes and serum were normal. This is the first report to document low polymorphonuclear magnesium content in patients with bronchial asthma. The reduction of polymorphonuclear magnesium content may have an important role in the pathogenesis of asthma.

Full text

PDF
441

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham W. M., Ahmed A., Cortes A., Sielczak M. W., Hinz W., Bouska J., Lanni C., Bell R. L. The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep. Eur J Pharmacol. 1992 Jul 7;217(2-3):119–126. doi: 10.1016/0014-2999(92)90829-s. [DOI] [PubMed] [Google Scholar]
  2. Aderem A. A., Cohn Z. A. Calcium ionophore synergizes with bacterial lipopolysaccharides in activating macrophage arachidonic acid metabolism. J Exp Med. 1988 Feb 1;167(2):623–631. doi: 10.1084/jem.167.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Akagi K., Townley R. G. Spontaneous histamine release and histamine content in normal subjects and subjects with asthma. J Allergy Clin Immunol. 1989 Apr;83(4):742–749. doi: 10.1016/0091-6749(89)90009-2. [DOI] [PubMed] [Google Scholar]
  4. Altura B. M., Altura B. T. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. II. Experimental aspects. Magnesium. 1985;4(5-6):245–271. [PubMed] [Google Scholar]
  5. Altura B. M., Altura B. T. Vascular smooth muscle and prostaglandins. Fed Proc. 1976 Oct;35(12):2360–2366. [PubMed] [Google Scholar]
  6. BOIS P., GASCON A., BEAULNES A. Histamine-liberating effect of magnesium deficiency in the rat. Nature. 1963 Feb 2;197:501–502. doi: 10.1038/197501a0. [DOI] [PubMed] [Google Scholar]
  7. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  8. ENGBAEK L. The pharmacological actions of magnesium ions with particular reference to the neuromuscular and the cardiovascular system. Pharmacol Rev. 1952 Dec;4(4):396–414. [PubMed] [Google Scholar]
  9. English D., Andersen B. R. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods. 1974 Aug;5(3):249–252. doi: 10.1016/0022-1759(74)90109-4. [DOI] [PubMed] [Google Scholar]
  10. Gaddy J. N., Busse W. W. Enhanced IgE-dependent basophil histamine release and airway reactivity in asthma. Am Rev Respir Dis. 1986 Nov;134(5):969–974. doi: 10.1164/arrd.1986.134.5.969. [DOI] [PubMed] [Google Scholar]
  11. Hardy C. C., Robinson C., Tattersfield A. E., Holgate S. T. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med. 1984 Jul 26;311(4):209–213. doi: 10.1056/NEJM198407263110401. [DOI] [PubMed] [Google Scholar]
  12. Hui K. P., Barnes N. C. Inhibition of leukotriene synthesis: new therapy in asthma? Pulm Pharmacol. 1993 Mar;6(1):3–9. doi: 10.1006/pulp.1993.1002. [DOI] [PubMed] [Google Scholar]
  13. Iseri L. T., French J. H. Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984 Jul;108(1):188–193. doi: 10.1016/0002-8703(84)90572-6. [DOI] [PubMed] [Google Scholar]
  14. Ishizaka K., Tomioka H., Ishizaka T. Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. J Immunol. 1970 Dec;105(6):1459–1467. [PubMed] [Google Scholar]
  15. Ishizaka T., Ishizaka K., Tomioka H. Release of histamine and slow reacting substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells. J Immunol. 1972 Feb;108(2):513–520. [PubMed] [Google Scholar]
  16. Kapuściński J., Skoczylas B. Simple and rapid fluorimetric method for DNA microassay. Anal Biochem. 1977 Nov;83(1):252–257. doi: 10.1016/0003-2697(77)90533-4. [DOI] [PubMed] [Google Scholar]
  17. Levine B. S., Coburn J. W. Magnesium, the mimic/antagonist to calcium. N Engl J Med. 1984 May 10;310(19):1253–1255. doi: 10.1056/NEJM198405103101910. [DOI] [PubMed] [Google Scholar]
  18. Maguire M. E. Hormonal regulation of magnesium uptake: differential coupling of membrane receptors to magnesium uptake. Magnesium. 1987;6(4):180–191. [PubMed] [Google Scholar]
  19. Mathew R., Altura B. M. Magnesium and the lungs. Magnesium. 1988;7(4):173–187. [PubMed] [Google Scholar]
  20. McNamara R. M., Spivey W. H., Skobeloff E., Jacubowitz S. Intravenous magnesium sulfate in the management of acute respiratory failure complicating asthma. Ann Emerg Med. 1989 Feb;18(2):197–199. doi: 10.1016/s0196-0644(89)80114-3. [DOI] [PubMed] [Google Scholar]
  21. Middleton E., Jr Antiasthmatic drug therapy and calcium ions: review of pathogenesis and role of calcium. J Pharm Sci. 1980 Feb;69(2):243–251. doi: 10.1002/jps.2600690244. [DOI] [PubMed] [Google Scholar]
  22. Nigam S., Averdunk R., Günther T. Alteration of prostanoid metabolism in rats with magnesium deficiency. Prostaglandins Leukot Med. 1986 Jul;23(1):1–10. doi: 10.1016/0262-1746(86)90070-3. [DOI] [PubMed] [Google Scholar]
  23. Okayama H., Aikawa T., Okayama M., Sasaki H., Mue S., Takishima T. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma. JAMA. 1987 Feb 27;257(8):1076–1078. [PubMed] [Google Scholar]
  24. Pacheco Y., Hosni R., Chabannes B., Gormand F., Moliere P., Grosclaude M., Piperno D., Lagarde M., Perrin-Fayolle M. Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest. 1992 Nov;22(11):732–739. doi: 10.1111/j.1365-2362.1992.tb01437.x. [DOI] [PubMed] [Google Scholar]
  25. Parker C. W., Smith J. W. Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest. 1973 Jan;52(1):48–59. doi: 10.1172/JCI107173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Reinhart R. A. Magnesium metabolism. A review with special reference to the relationship between intracellular content and serum levels. Arch Intern Med. 1988 Nov;148(11):2415–2420. doi: 10.1001/archinte.148.11.2415. [DOI] [PubMed] [Google Scholar]
  27. Rolla G., Bucca C., Arossa W., Bugiani M. Magnesium attenuates methacholine-induced bronchoconstriction in asthmatics. Magnesium. 1987;6(4):201–204. [PubMed] [Google Scholar]
  28. Rolla G., Bucca C., Bugiani M., Arossa W., Spinaci S. Reduction of histamine-induced bronchoconstriction by magnesium in asthmatic subjects. Allergy. 1987 Apr;42(3):186–188. doi: 10.1111/j.1398-9995.1987.tb02198.x. [DOI] [PubMed] [Google Scholar]
  29. Rolla G., Bucca C., Caria E., Arossa W., Bugiani M., Cesano L., Caropreso A. Acute effect of intravenous magnesium sulfate on airway obstruction of asthmatic patients. Ann Allergy. 1988 Nov;61(5):388–391. [PubMed] [Google Scholar]
  30. Rouzer C. A., Samuelsson B. Reversible, calcium-dependent membrane association of human leukocyte 5-lipoxygenase. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7393–7397. doi: 10.1073/pnas.84.21.7393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ryzen E., Elkayam U., Rude R. K. Low blood mononuclear cell magnesium in intensive cardiac care unit patients. Am Heart J. 1986 Mar;111(3):475–480. doi: 10.1016/0002-8703(86)90051-7. [DOI] [PubMed] [Google Scholar]
  32. Samuelsson B., Dahlén S. E., Lindgren J. A., Rouzer C. A., Serhan C. N. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987 Sep 4;237(4819):1171–1176. doi: 10.1126/science.2820055. [DOI] [PubMed] [Google Scholar]
  33. Schulman E. S., Newball H. H., Demers L. M., Fitzpatrick F. A., Adkinson N. F., Jr Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis. 1981 Oct;124(4):402–406. doi: 10.1164/arrd.1981.124.4.402. [DOI] [PubMed] [Google Scholar]
  34. Skobeloff E. M., Spivey W. H., McNamara R. M., Greenspon L. Intravenous magnesium sulfate for the treatment of acute asthma in the emergency department. JAMA. 1989 Sep 1;262(9):1210–1213. [PubMed] [Google Scholar]
  35. Ulevitch R. J., Watanabe Y., Sano M., Lister M. D., Deems R. A., Dennis E. A. Solubilization, purification, and characterization of a membrane-bound phospholipase A2 from the P388D1 macrophage-like cell line. J Biol Chem. 1988 Mar 5;263(7):3079–3085. [PubMed] [Google Scholar]
  36. Wegner C. D., Gundel R. H., Abraham W. M., Schulman E. S., Kontny M. J., Lazer E. S., Homon C. A., Graham A. G., Torcellini C. A., Clarke C. C. The role of 5-lipoxygenase products in preclinical models of asthma. J Allergy Clin Immunol. 1993 Apr;91(4):917–929. doi: 10.1016/0091-6749(93)90350-o. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES